# A Study of Efficacy and Safety of AX-8 in Chronic Cough

> **NCT04866563** · PHASE2 · COMPLETED · sponsor: **Axalbion SA** · enrollment: 108 (actual)

## Conditions studied

- Chronic Cough

## Interventions

- **DRUG:** AX-8, Part 1 of the study
- **DRUG:** Placebo, Part 1 of the study
- **DRUG:** AX-8, Part 2 of the study
- **DRUG:** Placebo, Part 2 of the study

## Key facts

- **NCT ID:** NCT04866563
- **Lead sponsor:** Axalbion SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-11
- **Primary completion:** 2025-06-16
- **Final completion:** 2025-06-16
- **Target enrollment:** 108 (ACTUAL)
- **Last updated:** 2025-09-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04866563

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04866563, "A Study of Efficacy and Safety of AX-8 in Chronic Cough". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04866563. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*